Raab & Moskowitz Asset Management LLC Biogen Inc. Transaction History

Raab & Moskowitz Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $186,235 - $246,636	-720 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $4,301 - $5,456	16 Added 2.27%	720 $227,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $154,922 - $214,065	704 New	704 $208,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $154,730 - $242,017	-714 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $183,869 - $219,133	714 New	714 $207,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.